[go: up one dir, main page]

PT99057A - Processo para a preparacao de composicoes farmaceuticas contendo uma mistura sinergica de glicoproteina cd4 da superficie das ceelulas ou de um seu analogo com um agente polianionico anti-hiv, nomeadamente um polissacarido sulfatado - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo uma mistura sinergica de glicoproteina cd4 da superficie das ceelulas ou de um seu analogo com um agente polianionico anti-hiv, nomeadamente um polissacarido sulfatado

Info

Publication number
PT99057A
PT99057A PT99057A PT9905791A PT99057A PT 99057 A PT99057 A PT 99057A PT 99057 A PT99057 A PT 99057A PT 9905791 A PT9905791 A PT 9905791A PT 99057 A PT99057 A PT 99057A
Authority
PT
Portugal
Prior art keywords
agent
hiv
pct
polynostain
ecelulas
Prior art date
Application number
PT99057A
Other languages
English (en)
Other versions
PT99057B (pt
Inventor
Donald Selwyn Davies
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of PT99057A publication Critical patent/PT99057A/pt
Publication of PT99057B publication Critical patent/PT99057B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/02—Esters
    • C08B31/06—Esters of inorganic acids
    • C08B31/063—Starch sulfates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99057A 1990-09-25 1991-09-25 Processo para a preparacao de composicoes farmaceuticas contendo uma mistura sinergica de glicoproteina cd4 da superficie das ceelulas ou de um seu analogo com um agente polianionico anti-hiv, nomeadamente um polissacarido sulfatado PT99057B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909020861A GB9020861D0 (en) 1990-09-25 1990-09-25 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT99057A true PT99057A (pt) 1992-08-31
PT99057B PT99057B (pt) 1999-02-26

Family

ID=10682722

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99057A PT99057B (pt) 1990-09-25 1991-09-25 Processo para a preparacao de composicoes farmaceuticas contendo uma mistura sinergica de glicoproteina cd4 da superficie das ceelulas ou de um seu analogo com um agente polianionico anti-hiv, nomeadamente um polissacarido sulfatado

Country Status (15)

Country Link
US (2) US5439892A (pt)
EP (1) EP0550532B1 (pt)
JP (1) JP3281373B2 (pt)
AT (1) ATE165005T1 (pt)
AU (1) AU649731B2 (pt)
CA (1) CA2092094C (pt)
DE (1) DE69129272T2 (pt)
DK (1) DK0550532T3 (pt)
ES (1) ES2113888T3 (pt)
GB (1) GB9020861D0 (pt)
IE (1) IE913340A1 (pt)
NZ (1) NZ239908A (pt)
PT (1) PT99057B (pt)
WO (1) WO1992004904A1 (pt)
ZA (1) ZA917597B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625193D0 (en) * 1996-12-04 1997-01-22 Ml Lab Plc Treatment of highly vascular tumours
ATE317703T1 (de) * 1997-06-12 2006-03-15 Innovata Plc Polymer-wirkstoff-konjugate zur behandlung von krebs
US6077503A (en) * 1997-07-30 2000-06-20 Amway Corporation Skin whitener composition containing mercaptodextran
US6821958B1 (en) 2001-03-06 2004-11-23 Roger K. Hershline Antiviral composition
US20050209189A1 (en) * 2001-03-06 2005-09-22 Roger Hershline Antiviral composition
AU2002358222A1 (en) * 2001-12-24 2003-07-15 Ml Laboratories Plc Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
US20040009953A1 (en) * 2002-01-10 2004-01-15 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2004064850A1 (en) * 2003-01-23 2004-08-05 Ml Laboratories Plc Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
WO2005004882A1 (en) * 2003-07-09 2005-01-20 Monash University Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US7285582B2 (en) * 2004-12-30 2007-10-23 Conocophillips Company Modified latex drag reducer and processes therefor and therewith
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967178A (en) * 1957-12-06 1961-01-03 Corn Products Co Method of producing gelling starch of high clarity
US3017407A (en) * 1958-08-18 1962-01-16 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
US3070595A (en) * 1960-10-28 1962-12-25 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
WO1989003684A1 (fr) * 1987-10-30 1989-05-05 Chugai Seiyaku Kabushiki Kaisha Agent anti-vih
GB9001687D0 (en) * 1990-01-25 1990-03-28 Ml Lab Plc Treatment of poisoning and composition for use therein
US5221669A (en) * 1991-04-19 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections

Also Published As

Publication number Publication date
EP0550532A1 (en) 1993-07-14
DE69129272T2 (de) 1998-11-12
PT99057B (pt) 1999-02-26
AU649731B2 (en) 1994-06-02
ES2113888T3 (es) 1998-05-16
ZA917597B (en) 1992-05-27
DE69129272D1 (de) 1998-05-20
CA2092094C (en) 2004-08-10
DK0550532T3 (da) 1999-03-08
US5439892A (en) 1995-08-08
ATE165005T1 (de) 1998-05-15
GB9020861D0 (en) 1990-11-07
AU8614591A (en) 1992-04-15
JPH06503305A (ja) 1994-04-14
JP3281373B2 (ja) 2002-05-13
IE913340A1 (en) 1992-02-25
EP0550532B1 (en) 1998-04-15
WO1992004904A1 (en) 1992-04-02
US6015799A (en) 2000-01-18
CA2092094A1 (en) 1992-03-26
NZ239908A (en) 1993-03-26

Similar Documents

Publication Publication Date Title
PT99057A (pt) Processo para a preparacao de composicoes farmaceuticas contendo uma mistura sinergica de glicoproteina cd4 da superficie das ceelulas ou de um seu analogo com um agente polianionico anti-hiv, nomeadamente um polissacarido sulfatado
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
ES2164905T3 (es) Composicion antimicrobiana de tratamiento de cabello.
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
AR019388A1 (es) (3s) tetrahidro-3-furanil (1s, 2r)-3-[[(4-aminofenil)sulfonil)](isobutil)amino]-1-bencil-2-(fosfonooxi)propilcarbamato de calcio y composiciones del mismo,su uso en el tratamiento de infecciones retrovirales y procesos para su preparacion.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
BR9714272A (pt) Taxóide, composição farmacêutica tendo atividade de inversão de resistência a medicamento, e, processo para tratar tumores
ATE177641T1 (de) Zubereitungen von hyaluronsaeure mit niedrigem molekulargewicht zur foerderung der knochenbildung
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
BR9910071A (pt) Composição farmacêutica, processos para aumentar e manter a homogeneidade de uma composição farmacêutica e para tratar, reverter, reduzir ou inibir infecções retrovirais, uso de abacavir, lamivudina, zidovudina ou de um derivado farmaceuticamente aceitável dos mesmos, e de um agente de deslizamento farmaceuticamente aceitável, artigo de manufatura, e, processo para a preparação de uma composição farmacêutica
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
BR0206775A (pt) Uso de um medicamento para tratar um indivìduo infectado com hiv, por combinação de imunização com interrupção estruturada do tratamento anti-retrovirótico
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
MC1930A1 (fr) Produit antiviral
BR9712614A (pt) Composição farmacêutica,processos para aumentar e manter a homogeneidade de uma composição farmac&eutica,para tratar,reverter,reduzir ou inibir infeccões retrovirais e para preparação de uma composição farmacêutica,uso de lamivudina ou de um derivado farmaceuticamenete aceitável da mesma,de zidovudina,ou de um derivado farmaceuticamente aceitável da mesma e de um agente de deslizamento farmaceuticamente aceitável,e, artigo de amnufatura.
HU9201267D0 (en) Method for producing pharmaceutical preparatives containing gfi
BR0212744A (pt) Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
EP1362593A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING DIABETIC NEUROPATHY
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920407

FG3A Patent granted, date of granting

Effective date: 19981112

MM3A Annulment or lapse

Effective date: 20060512